All News

Pancreatic Cancer Action Network Appoints Michael Korengold as Chair of its Board of Directors

July 19, 2022

We are excited to announce that Enhanced Capital President and CEO, Michael Korengold, has been appointed chair of the Pancreatic Cancer Action Network’s (PanCAN) Board of Directors. Michael first joined PanCAN's Board of Directors in 2014.

PanCAN's Board comprises dedicated individuals who are leaders in their communities with a broad range of professional expertise, including business management, revenue generation, corporate operations, finance, legal, and Board governance. Each member has been personally impacted by pancreatic cancer and strives to help PanCAN increase funding, awareness, and ultimately, the pancreatic cancer survival rate.

"PanCAN's growth and the breadth of its impact has been breathtaking, but rapid growth brings different types of challenges, and I hope to be able to help the organization navigate the unique issues that it may face today," said Korengold. "I'm motivated by tangible improvements in the survival rate, by the expansion of clinical trials, efforts in early detection and expansion of services to patients and, more than anything, the increased sense of hope in place of the past sense that a pancreatic cancer diagnosis was a death sentence."

Read the Pancreatic Cancer Action Network’s full press release: The Pancreatic Cancer Action Network (PanCAN) Appoints New Chair and Welcomes New Member to its Board of Directors

About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network (PanCAN) leads the way in accelerating critical progress for pancreatic cancer patients. PanCAN takes bold action by funding life-saving research, providing personalized patient services and creating a community of supporters and volunteers who will stop at nothing to create a world in which all pancreatic cancer patients will thrive.